The rising application of algae in nutraceuticals & pharmaceutical industries has influenced the market growth in the recent past. The growing use of algae biomass for nutraceuticals purposes is expected to provide an attractive revenue stream for algae producers. Further, the growing industrial application of algae is providing business opportunities to the companies that have further impacted the market growth. Some companies are offering algae-based CO2 capturing and biofuel production that has opened a new revenue stream for their company.
This report on global autoimmune diseases treatment market studies various drugs used for treatment of autoimmune diseases along with pipeline analysis of upcoming potential drugs. Autoimmune diseases (ADs) are a family of more than 80 chronic, and often disabling, illnesses broadly characterized by immune system dysfunction leading to the loss of tolerance to self-antigens, presence of increased level of autoantibodies, inflammatory and mediatory cells and resulting chronic inflammation.
Hot and cold therapy packs market is expected to grow at 10.0% by 2033. Hot and cold therapy packs are medical products that provide comfort from pain arising through injury or other causes. The global market for hot and cold therapy packs is driven by growth in injury incidences resulting in pain, rise in geriatric population, and preference for non-invasive pain management methods.
Sodium thiocyanate is a chemical compound which appears to be colorless or white powder. This powder easily dissolves in ethanol, water and acetone. It is a rhombic system crystal which has relative density 1.735 and melting point of 287 degree Celsius. Sodium thiocyanate decomposes on heating under light and produces harmful fumes of sulfur oxide, cyanides and nitrogen oxides. It reacts vigorously with strong bases, acids and strong oxidants.
According to Cleveland Clinic, venous thromboembolism (VTE) is a disease that includes both deep vein thrombosis (DVT) and pulmonary embolism (PE). It is a common, lethal disorder that affects hospitalized and non-hospitalized patients, recurs frequently, is often overlooked, and results in long-term complications including chronic thromboembolic pulmonary hypertension (CTPH) and the post-thrombotic syndrome (PTS).
This report on global Listeria monocytogenes infections treatment market studies various drugs used for treatment of Listeria monocytogenes infection’s along with pipeline analysis of upcoming potential drugs. According to Centers for Disease Control and Prevention (CDC), Listeriosis, a serious infection usually caused by eating food contaminated with the bacterium Listeria monocytogenes, is an important public health problem in the United States.
The global osteoarthritis treatment market is projected to grow at a CAGR of 9 %.Improving healthcare sector, treatment types, safety& emerging technologies are driving the market growth. Osteoarthritis is the most common form of arthritis, affecting millions of people worldwide. It occurs when the protective cartilage that cushions the ends of your bones wears down over time.
Butyric acid is a colorless chemical used in various applications such as animal feed, chemical intermediate, food and flavors, pharmaceuticals and others. In 2014, animal feed accounted for 40% share of the total market in terms of value and projected to maintain its dominance during the forecast period. However, food and flavors segment is projected to witness highest growth rate during the forecast period.
Medical waste is generated in healthcare facilities, medical research institutions and medical laboratories. Appropriate management of medical waste is the prime responsibility of medical facilities as these type of waste often have direct impact on community health, environment and other intermediaries, and demand appropriate control and disposal. Medical waste management comprises activities such as handling, storage, transport, processing and disposal of waste generated.
Fermentation technology has been a long favored biological process due to its simplicity of reaction, low costs, versatility of application and high specificity. Industries have complimented the basic principle of fermentation with advance in techniques and genetic engineering.
The drugs by therapeutic area market covers pharmaceutical products classified according to the diseases and medical conditions they are designed to treat. Major therapeutic areas include oncology, cardiovascular diseases, diabetes and other metabolic disorders, neurological conditions, infectious diseases, respiratory disorders, immunology, gastrointestinal diseases, dermatology, ophthalmology, women’s health and rare diseases. The category includes prescription drugs, generic medicines, biologics, biosimilars, vaccines and advanced therapies.
The wider global pharmaceutical market provides an appropriate benchmark for evaluating growth across therapeutic drug categories. One current industry estimate projects the pharmaceutical market to increase from approximately USD 1.88 trillion in 2026 to USD 3.22 trillion by 2035, representing a compound annual growth rate of 6.15%. North America held the largest regional share in 2025, while Asia-Pacific is expected to demonstrate notable growth through 2035.
Market growth is being supported by the increasing prevalence of chronic and age-related diseases. Rising cases of cancer, diabetes, cardiovascular disorders, arthritis, respiratory diseases and neurological conditions are creating sustained demand for effective treatments. Population ageing, lifestyle changes, urbanization and improved access to diagnosis are further expanding the number of patients receiving long-term therapy.
Oncology remains an important area for pharmaceutical research and commercial investment. Development activity includes targeted therapies, immune checkpoint inhibitors, antibody-drug conjugates, cell therapies and personalized cancer treatments. Diabetes and obesity drugs are also recording strong demand, supported by the wider use of GLP-1 and other metabolic treatments. Neurology research is expanding across Alzheimer’s disease, Parkinson’s disease, epilepsy and mental health conditions.
Biologic drugs and biosimilars represent major market trends. Biologics are increasingly used to treat cancer, autoimmune diseases and rare disorders, while biosimilars can improve access after reference-product patent expiry. Pharmaceutical companies are also developing gene therapies, RNA-based medicines and other advanced treatments for conditions with limited existing options.
Precision medicine is influencing drug development across multiple therapeutic areas. Biomarkers, genomic testing and companion diagnostics help identify patients who are more likely to respond to specific medicines. Artificial intelligence is also being used for target identification, clinical-trial planning and analysis of real-world treatment data.
Market expansion may be restrained by high research costs, lengthy clinical development, regulatory uncertainty and drug-pricing pressure. Patent expirations can reduce revenue for branded products, while safety concerns or unsuccessful clinical trials may delay commercial launches. Access and reimbursement remain major challenges for expensive biologics and advanced therapies.
Acute Market Reports provides therapeutic-area drug research covering product classes, disease indications, routes of administration, distribution channels, company pipelines, competitive conditions and regional opportunities. These reports help pharmaceutical companies, investors, healthcare providers and distributors evaluate treatment demand and growth prospects through 2035.